APA (7th ed.) Citation

L, S., JL, M., WA, C., M, M., E, C., JJ, H., . . . ATN, T. (2026). Intrapartum oral azithromycin for maternal infection prophylaxis and the risk of postpartum hemorrhage: A secondary analysis of the A-PLUS trial. International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics, 173(3), 1562. https://doi.org/10.1002/ijgo.70777

Chicago Style (17th ed.) Citation

L, Sidze, et al. "Intrapartum Oral Azithromycin for Maternal Infection Prophylaxis and the Risk of Postpartum Hemorrhage: A secondary Analysis of the A-PLUS Trial." International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics 173, no. 3 (2026): 1562. https://doi.org/10.1002/ijgo.70777.

MLA (9th ed.) Citation

L, Sidze, et al. "Intrapartum Oral Azithromycin for Maternal Infection Prophylaxis and the Risk of Postpartum Hemorrhage: A secondary Analysis of the A-PLUS Trial." International Journal of Gynaecology and Obstetrics: The Official Organ of the International Federation of Gynaecology and Obstetrics, vol. 173, no. 3, 2026, p. 1562, https://doi.org/10.1002/ijgo.70777.